Avoidant/restrictive food intake disorder (ARFID) is a serious eating disorder that goes far beyond typical picky eating, affecting both children and adults with potentially severe health consequences. Unlike more widely known disorders such as anorexia nervosa and bulimia, ARFID is not associated with concerns about body image. Instead, it involves an intense avoidance or restriction of food due to a variety of factors, including fear of adverse consequences like choking, sensory sensitivities, or simply a lack of interest in eating. Recent years have seen a notable rise in ARFID diagnoses, prompting healthcare providers and researchers to deepen their understanding of the condition’s causes, symptoms, and treatments.
The story of Stella, an eight-year-old girl, illustrates the severity and complexity of ARFID. Once a child who enjoyed a variety of foods, Stella gradually stopped eating solid foods and eventually limited her diet to liquids. Her restrictive eating worsened over time, as she began removing chunks from her soup and avoiding smoothies containing small seeds. She developed a profound fear of choking, to the point where she even spit out her saliva. Within a month, Stella became severely malnourished and exhausted, leading her parents to take her to the hospital. There, doctors placed her on a feeding tube and quickly diagnosed her with ARFID. The rapid weight loss raised concerns about potential heart problems, underscoring how dangerous the disorder can be if left untreated.
Clinicians stress that ARFID is much more than mere picky eating, which is common and developmentally normal in many young children between the ages of two and six. ARFID involves persistent food avoidance that leads to significant nutritional deficiencies, weight loss, and physical symptoms such as vitamin deficiencies, irregular menstrual cycles, low testosterone, hair and muscle loss, and chronic coldness. In children, the disorder can cause them to fall off standard growth charts used to track healthy development in the United States. Because of these serious health impacts, doctors often recommend nutritional supplements or interventions to prevent long-term developmental issues.
James Lock, a psychiatry professor at Stanford University School of Medicine and director of their Child and Adolescent Eating Disorder Program, emphasizes the difference between typical picky eating and ARFID. “We’re not just trying to treat kids who don’t like broccoli. It’s the kid who is malnourished as a result of their food choices,” he says. ARFID was officially recognized as a distinct feeding and eating disorder in 2013 when it was included in the Diagnostic and Statistical Manual of Mental Disorders (DSM). This formal recognition helped clinicians identify and label a condition that had often gone undetected or misunderstood.
Jennifer Thomas, co-director of the Eating Disorders Clinical and Research Program at Massachusetts General Hospital, notes that stigma likely contributed to underreporting and underdiagnosis in the past. “Probably there were people who had this syndrome, but they didn’t really talk about it because there’s a stigma around it,” she explains. Greater awareness and recognition of ARFID have contributed to the recent surge in diagnosed cases, although comprehensive data remain scarce.
Prevalence estimates vary widely, with global rates ranging from approximately 0.35% to 3% across all age groups according to some studies. Certain countries report higher rates; for example, a recent study in the Netherlands found that 6.4% of children aged 10 had ARFID. In the United States, specialized clinics like Equip, which treated Stella after her hospitalization, report dramatic increases in patient numbers. Equip treated over 1,000 people with ARFID in 2024, representing a 144% increase from the previous year.
Jessie Menzel, a clinical psychologist who treats ARFID, highlights the disorder’s complexity: “I think that’s one of the things that has made ARFID a challenging eating disorder [to diagnose]—because it is a lot of different things.” According to the National Alliance for Eating Disorders, ARFID now accounts for up to 15% of all new eating disorder cases. While it can affect people of any age, most new diagnoses occur in children and adolescents, with an average diagnosis age of about 11 years. Notably, boys make up 20 to 30% of cases, a much higher proportion than seen in other eating disorders.
One of the defining characteristics of ARFID is that it is not driven by body image concerns. Instead, the disorder centers on the food itself and the individual’s emotional or physiological responses to it. Research categor